These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
760 related articles for article (PubMed ID: 19720055)
21. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration. Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284 [TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106 [TBL] [Abstract][Full Text] [Related]
23. Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells. Rubio S; Quintana J; Eiroa JL; Triana J; Estévez F Mol Carcinog; 2010 Jan; 49(1):32-43. PubMed ID: 19676104 [TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Han YH; Kim SZ; Kim SH; Park WH Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383 [TBL] [Abstract][Full Text] [Related]
25. Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo. Chang YF; Chi CW; Chern YT; Wang JJ Toxicol Appl Pharmacol; 2005 Jan; 202(1):1-12. PubMed ID: 15589971 [TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444 [TBL] [Abstract][Full Text] [Related]
27. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells. Liu WH; Cheng YC; Chang LS J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563 [TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells. Ding SZ; Smith MF; Goldberg JB J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686 [TBL] [Abstract][Full Text] [Related]
29. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652 [TBL] [Abstract][Full Text] [Related]
30. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells. Wang Y; An R; Dong X; Pan S; Duan G; Sun X Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013 [TBL] [Abstract][Full Text] [Related]
31. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation. Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710 [TBL] [Abstract][Full Text] [Related]
32. Adaphostin promotes caffeine-evoked autocrine Fas-mediated death pathway activation in Bcr/Abl-positive leukaemia cells. Liu WH; Chang LS Biochem J; 2011 Nov; 439(3):453-67. PubMed ID: 21745187 [TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process. Yu C; Rahmani M; Almenara J; Sausville EA; Dent P; Grant S Oncogene; 2004 Feb; 23(7):1364-76. PubMed ID: 14647418 [TBL] [Abstract][Full Text] [Related]
34. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling. Zhou J; Chen Y; Lang JY; Lu JJ; Ding J Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480 [TBL] [Abstract][Full Text] [Related]
35. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Chen L; Liu L; Yin J; Luo Y; Huang S Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine. Han YH; Kim SZ; Kim SH; Park WH Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767 [TBL] [Abstract][Full Text] [Related]
37. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione. Xiao G; Tang X; Yao C; Wang C Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):712-21. PubMed ID: 21785114 [TBL] [Abstract][Full Text] [Related]
38. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione. Fernández C; Ramos AM; Sancho P; Amrán D; de Blas E; Aller P J Biol Chem; 2004 Jan; 279(5):3877-84. PubMed ID: 14610070 [TBL] [Abstract][Full Text] [Related]
39. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells. Chen YJ; Wang JJ; Chang LS Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174 [TBL] [Abstract][Full Text] [Related]
40. Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3. Lu T; Huang CC; Lu YC; Lin KL; Liu SI; Wang BW; Chang PM; Chen IS; Chen SS; Tsai JY; Chou CT; Jan CR Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):297-303. PubMed ID: 18986328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]